Data Set: Systemic Anti-Cancer Therapy Data Set

Systemic Anti-Cancer Therapy Data Set

Systemic Anti-Cancer Therapy Data Set Overview

The Systemic Anti-Cancer Therapy Data Set has been incorporated early to allow users to see the changes, but please note that the implementation date is 1 April 2012.

The Systemic Anti-Cancer Therapy Data Set is intended to collect clinical management information on PATIENTS undergoing Chemotherapy in (or funded by) the NHS in England.

The Mandatory, Required or Optional (M/R/O) column indicates the recommendation for the inclusion of data.

M = Mandatory: this data element is mandatory, the message will be rejected if this data element is absent
R = Required: data is required as part of NHS business rules and must be included where available or applicable
O = Optional: the flow of this data is optional. It should be included at the discretion of the submitting organisation and their commissioners as required for local purposes.

DEMOGRAPHICS AND CONSULTANT

To carry personal, organisation and consultant details. One occurrence of this group is required.
M/R/O	Data Set Data Elements
M	NHS NUMBER
M	PERSON BIRTH DATE
R	PERSON GENDER CODE CURRENT
R	ETHNIC CATEGORY
M	POSTCODE OF USUAL ADDRESS
R	GENERAL MEDICAL PRACTICE CODE (PATIENT REGISTRATION)
R	CONSULTANT CODE (INITIATED SYSTEMIC ANTI-CANCER THERAPY)
R	CARE PROFESSIONAL MAIN SPECIALTY CODE (START SYSTEMIC ANTI-CANCER THERAPY)
M	ORGANISATION CODE (CODE OF PROVIDER)

CLINICAL STATUS

To carry the clinical status details. One occurrence of this group is required.
M/R/O	Data Set Data Elements
M	PRIMARY DIAGNOSIS (ICD AT START SYSTEMIC ANTI-CANCER THERAPY) and/or MORPHOLOGY (ICD-O AT START SYSTEMIC ANTI-CANCER THERAPY)
R	TNM CATEGORY (FINAL PRETREATMENT)

PROGRAMME AND REGIMEN

To carry details of the Systemic Anti-Cancer Therapy Programme and Systemic Anti-Cancer Drug Regimen. Multiple occurrences of this group are permitted (at least one must be present).
M/R/O	Data Set Data Elements
R	SYSTEMIC ANTI-CANCER THERAPY PROGRAMME NUMBER
R	ANTI-CANCER REGIMEN NUMBER
R	DRUG TREATMENT INTENT
M	DRUG REGIMEN ACRONYM
R	PERSON HEIGHT IN METRES
R	PERSON WEIGHT
R	PERFORMANCE STATUS (ADULT) or PERFORMANCE STATUS (YOUNG PERSON)
R	CO-MORBIDITY ADJUSTMENT INDICATOR
R	DECISION TO TREAT DATE (ANTI-CANCER DRUG REGIMEN)
M	START DATE (ANTI-CANCER DRUG REGIMEN)
R	CLINICAL TRIAL INDICATOR
R	CHEMO-RADIATION INDICATOR
R	NUMBER OF SYSTEMIC ANTI-CANCER THERAPY CYCLES PLANNED

CYCLE

To carry details of each Systemic Anti-Cancer Therapy Cycle. Multiple occurrences of this group are permitted (at least one must be present).
M/R/O	Data Set Data Elements
M	ANTI-CANCER DRUG CYCLE IDENTIFIER
R	START DATE (SYSTEMIC ANTI-CANCER DRUG CYCLE)
O	PERSON WEIGHT
R	PERFORMANCE STATUS (ADULT) or PERFORMANCE STATUS (YOUNG PERSON)
R	PRIMARY PROCEDURE (OPCS)

DRUG DETAILS

To carry details of the Systemic Anti-Cancer Therapy Drugs. Multiple occurrences of this group are permitted (one occurrence for each Systemic Anti-Cancer Therapy Drug - at least one must be present).
M/R/O	Data Set Data Elements
R	SYSTEMIC ANTI-CANCER DRUG NAME
R	CHEMOTHERAPY ACTUAL DOSE
R	SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION
R	SYSTEMIC ANTI-CANCER THERAPY ADMINISTRATION DATE
R	ORGANISATION CODE (CODE OF PROVIDER)
R	PRIMARY PROCEDURE (OPCS)

OUTCOME

To carry details of the outcome / summary. One occurrence of this group is permitted.
M/R/O	Data Set Data Elements
R	START DATE (FINAL SYSTEMIC ANTI-CANCER THERAPY)
R	SYSTEMIC ANTI-CANCER THERAPY REGIMEN MODIFICATION INDICATOR (DOSE REDUCTION)
R	SYSTEMIC ANTI-CANCER THERAPY REGIMEN MODIFICATION INDICATOR (TIME DELAY)
R	SYSTEMIC ANTI-CANCER THERAPY REGIMEN MODIFICATION INDICATOR (DAYS REDUCED)
R	PLANNED TREATMENT CHANGE REASON
R	PERSON DEATH DATE